永興材料(002756.SZ):第三季度淨利預增675.12%-764.02%
格隆匯10月14日丨永興材料(002756.SZ)披露2022年前三季度業績預吿,預計2022年前三季度實現歸屬於上市公司股東的淨利潤41.83億元-44.03億元,同比增長660.00%-700.00%。其中,第三季度歸屬於上市公司股東的淨利潤為19.19億元-21.39億元,同比增長675.12%-764.02%。
今年以來,新能源汽車及儲能行業維持快速發展態勢,下游客户對鋰鹽保持強勁需求,帶動碳酸鋰價格持續上漲並逐步穩定在較高水平。報吿期內,公司鋰電新能源業務產銷量持續提升,業績增長明顯。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.